High-dose versus standard-dose rituximab with BEAM in autologous stem cell transplantation (SCT) for relapsed aggressive b-cell non-Hodgkin's lymphomas (NHL).

被引：0
|
作者：
Srour, Samer Ali [1 ]
Khouri, Issa F. [1 ]
Nieto, Yago [1 ]
Popat, Uday R. [1 ]
Qazilbash, Muzaffar H. [1 ]
Anderlini, Paolo [1 ]
Kebriaei, Partow [1 ]
Shpall, Elizabeth J. [1 ]
Champlin, Richard E. [1 ]
Hosing, Chitra [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.7524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7524
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficiency of in vivo purging with Rituximba following by high-dose therapy (HDT) with autologous peripheral blood stem cell transplantation (PBSCT) in B-cell non-Hodgkin's lymphomas (NHL).: A single institution study.
    Haioun, C
    Delfau-Larue, MH
    Beaujean, F
    Beaumont, JL
    Belhadj, K
    Pautas, C
    Kirova, Y
    Allain, A
    Gaulard, P
    Farcet, JP
    Reyes, F
    BLOOD, 2000, 96 (11) : 184A - 184A
  • [32] High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)
    Oyan, B
    Koc, Y
    Ozdemir, E
    Kansu, E
    BLOOD, 2004, 104 (11) : 393B - 393B
  • [33] High-Dose Therapy and Autologous Stem Cell Transplant (HD-ASCT) for Transformed Non-Hodgkin Lymphoma (NHL) In the Rituximab Era
    Ban-Hoefen, Makiko
    Friedberg, Jonathan W.
    Kelly, Jennifer L.
    Bernstein, Steven H.
    Liesveld, Jane L.
    Young, Faith
    Fisher, Richard I.
    Constine, Louis
    Becker, Michael
    Phillips, Gordon L., II
    BLOOD, 2010, 116 (21) : 992 - 992
  • [34] High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era
    Ban-Hoefen, Makiko
    Kelly, Jennifer L.
    Bernstein, Steven H.
    Liesveld, Jane
    Constine, Louis
    Becker, Michael
    Milner, Laurie
    Phillips, Gordon
    Friedberg, Jonathan W.
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 830 - 835
  • [35] High-dose therapy with peripheral blood stem cell (PBSC) transplantation in patients with low-grade non-Hodgkin's lymphomas (NHL).
    Martin, S
    Moos, M
    Voso, MT
    Hohaus, S
    Ho, AD
    Haas, R
    BLOOD, 1998, 92 (10) : 460A - 460A
  • [36] Autologous bone marrow transplantation (ABMT) for marginal zone B-cell non-Hodgkin's lymphomas (NHL).
    Gaudet, G
    Friedberg, J
    Kutok, J
    Neuberg, D
    Nadler, LM
    Freedman, AS
    BLOOD, 2001, 98 (11) : 392B - 392B
  • [37] High-Dose Chemotherapy (HDC) and Autologous Stem Cell Transplantation (ASCT) in patients with primary refractory aggressive Non-Hodgkin's lymphoma
    Rodriguez, J
    Caballero, MD
    Solano, C
    Lahuerta, JJ
    Arranz, R
    Sureda, A
    Zuazu, J
    Marin, J
    García-Laraña, J
    López-Guillermo, A
    SanMiguel, J
    Conde, E
    BONE MARROW TRANSPLANTATION, 2001, 27 : S260 - S261
  • [38] Phase II trial of rituximab as adjuvant therapy to high dose chemotherapy and peripheral blood stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphomas.
    Horwitz, SM
    Negrin, RS
    Stockerl-Goldstein, KE
    Johnston, LJ
    Shizuru, JA
    Stuart, MJ
    Breslin, S
    Blume, KG
    Horning, SJ
    BLOOD, 2001, 98 (11) : 862A - 862A
  • [39] Remission duration inversions following high-dose therapy and autologous hematopoietic cell transplantation for relapsed low grade non-Hodgkin's lymphoma (NHL).
    Perry, J
    Case, D
    Shipley, D
    Melisko, M
    Cruz, J
    Radford, J
    Ferree, C
    Hurd, D
    BLOOD, 1996, 88 (10) : 465 - 465
  • [40] High-dose rituximab in combination with autologous stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma
    Shi, Yi-Fen
    Zhou, Shu-Juan
    Sun, Lan
    Yu, Kang
    Chen, Yi
    MEDICINA CLINICA, 2020, 155 (06): : 235 - 241
12345